This episode explores vaccines and immune globulins as anticipatory medicine. Instead of treating disease after damage occurs, these interventions shape immune memory, readiness, and rapid response. We contrast active immunisation with passive protection, examine how antigen design and delivery influence durability, and frame adverse effects as predictable consequences of immune education rather than failure.

Key takeaways you’ll build and reuse throughout the series:

* Active versus passive immunity: training the immune system versus lending it temporary protection.

* Vaccine platforms in principle: live attenuated, inactivated, subunit, conjugate, and newer biologic approaches.

* Immune memory and timing: priming, boosting, waning immunity, and population-level protection.

* Immune globulins in practice: post-exposure prophylaxis, immunodeficiency support, and targeted neutralisation.

* Safety and trust: reactogenicity, rare adverse events, and why benefit is measured in disease prevented, not felt.

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe